Randomised trial to determine the safety and efficacy of early versus deferred treatment of adult HIV infection

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The purpose of this randomised study is to determine whether the use of combination antiviral drugs during early stages of HIV disease is superior to later use in adults with HIV infection. Superiority is defined in terms of reducing the number of serious diseases and deaths that are associated with HIV infection.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $417,254.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Antiretroviral therapy | Clinical endpoint trial | Early versus Deferred Treatment | HIV-AIDS | Morbidity and Mortality | Randomised Clinical Trial